Why the study?
Uncertainties exist regarding when to transition patients to oral loop diuretics before discharge after managing acute decompensated heart failure.
Does an observation duration of ≥24 hours after switching to oral loop diuretics reduce 30-day all-cause readmission in adult patients with acute decompensated heart failure?
Does an observation duration of ≥24 hours after switching to oral loop diuretics reduce 30-day all-cause readmission in adult patients with acute decompensated heart failure?
Observing patients for at least 24 hours after transitioning to oral loop diuretics prior to discharge for acute decompensated heart failure is associated with a significant reduction in 30-day all-cause readmissions.
Answers are grounded in this paper and cite their sources.
May support ≥24 h observation after oral diuretic transition in ADHF; hypothesis-generating and requires randomized confirmation.
There are uncertainties when to start patients on oral loop diuretics after managing acute decompensated heart failure (ADHF) before discharge. This study aims to investigate the impact of prolonging observation duration on hospital readmissions following the switch to oral loop diuretics before discharge in patients with ADHF. A multicenter retrospective study that included adult patients (>18 years) diagnosed with ADHF and discharged on oral loop diuretics in Saudi Arabia. Patients who received oral loop diuretics were divided into 2 groups based on the observation duration before discharge. The primary outcome was a 30-day readmission rate for all causes; the secondary outcomes were 60- and 90-day readmission rates for all causes; and 30-, 60-, and 90-day readmission rates for heart failure. A total of 400 ADHF patients were included in the final analysis. Patients in group 1 (n = 142; < 24 hours) and group 2 (n = 258; ≥ 24 hours) had similar baseline characteristics (P > .05), except for the length of hospital stay (P = .03) and total observation time (P = <.01). ADHF patients with <24 hours observation durations were significantly associated with higher all-cause 30-day readmissions compared to those with ≥24 hours observations (odds ratio = 1.83, 95% confidence interval = 1.11-3.02, P = .017). Our study showed a significant decrease in all-cause 30-day readmissions for ADHF patients who received oral loop diuretics at discharge with a longer duration of observation. This study emphasizes the significance of standardizing the observational period when initiating oral loop diuretics before discharge following admission to ADHF.
No takes yet. Share an insight, caveat, or question.
Alshibani et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: